Author(s):
Yasser Bustanji
Email(s):
ybustanji@sharjah.ac.ae
DOI:
10.52711/0974-360X.2026.00505 
Address:
Yasser Bustanji1,2,3
1School of Pharmacy, The University of Jordan, Amman 11942.
2Research Institute of Medical and Health Sciences, University of Sharjah, Sharjah 27272 United Arab Emirates.
3College of Medicine, University of Sharjah, Sharjah 27272 United Arab Emirates.
*Corresponding Author
Published In:
Volume - 19,
Issue - 8,
Year - 2026
ABSTRACT:
Background: Cancer is a growing global health burden, and while high-income countries dominate oncology research, low- and middle-income countries such as Jordan face increasing cancer incidence with limited representation in global scientific literature. This study presents the first comprehensive bibliometric analysis of Jordan's contribution to global cancer research from 1974 to 2024. Objectives: To evaluate the research output, impact, thematic trends, and international collaboration patterns of Jordanian cancer research over the past 50 years and to assess its alignment with national cancer priorities. Methods: A bibliometric analysis was conducted using the Scopus database for peer-reviewed original research articles affiliated with Jordanian institutions from 1974 to 2024. Data were analyzed using VOSviewer and Bibliometrix (R package). Trends in publication volume, citation impact, collaboration networks, journal performance and author keyword spots were explored. Results: Among 6,975 cancer-related papers, there are 5,314 original research publications were examined. About 59.8% of publications were published in the last five years, growing 14.5% annually. Jordan contributed 0.134% of global cancer research with 138,461 citations and h-index 111. Jordan University, Jordan University of Science and Technology (JUST), and King Hussein Cancer Center (KHCC) were research hubs. Epidemiology and preventive, clinical management and palliative care, molecular and cellular biology, and therapeutic innovation (including nanotechnology and AI) were identified as research themes using author keyword analysis. Conclusions: Jordan's cancer research has shown remarkable growth in both volume and impact. While historically underrepresented, the country now contributes significantly to global oncology literature across a broad spectrum of domains.
Cite this article:
Yasser Bustanji. Fifty Years of Progress: A Bibliometric Analysis of Jordan's Contribution to Global Cancer Research . Research Journal of Pharmacy and Technology. 2026;19(8):3569-6. doi: 10.52711/0974-360X.2026.00505
Cite(Electronic):
Yasser Bustanji. Fifty Years of Progress: A Bibliometric Analysis of Jordan's Contribution to Global Cancer Research . Research Journal of Pharmacy and Technology. 2026;19(8):3569-6. doi: 10.52711/0974-360X.2026.00505 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2026-19-8-22
7. REFERENCES:
1. Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2024; 74(3): 229-63.
2. Zhou J, Xu Y, Liu J, Feng L, Yu J, Chen D. Global burden of lung cancer in 2022 and projections to 2050: Incidence and mortality estimates from GLOBOCAN. Cancer Epidemiol 2024; 93.
3. Abdel-Razeq H, Attiga F, Mansour A. Cancer care in Jordan. Hematol Oncol Stem Cell Ther 2015; 8(2): 64-70.
4. Rihani R, Awidi A, Barbar M, et al. Advancing paediatric cancer care in Jordan: a strategic 10-year roadmap. Lancet Child Adolesc Health 2025; 9(7): 497-507.
5. Khatib S, Nimri O. General Oncology Care in Jordan. In: Al-Shamsi HO, Abu-Gheida IH, Iqbal F, Al-Awadhi A, eds. Cancer in the Arab World. Singapore: Springer Singapore; 2022: 83-98.
6. Pawar S. Bibliometric: A Research Technique. International Journal of Advanced Social Sciences. 2020; 8(3): 105-10.
7. Bustanji Y, Taneera J, Bargooth A, et al. Exploring the Global Landscape of Self-Medication Among Students: Trends, Risks, and Recommendations for Safe and Responsible Practices. Pharm Pract 2024; 22(1).
8. Perwitasari DA, Maliza R. Trend In the Publication of Study on Systemic Lupus Erythematosus (SLE) In 2012-2020 Period: A Bibliometric Analysis. Res J Pharm Technol. 2024; 17(3): 1076-82.
9. Rao USM, Bhattacharya D, Basukala JM, Tripathy CS. Punica granatum and Ellagic Acid in Health Care Functional Fruit: Unique Bibliography. Res J Pharm Technol. 2024; 17(1): 452-9.
10. Ansorge L. Bibliometric Studies as a Publication Strategy. Metrics, 2024. accessed.
11. Kiromah NZW, Sugihartini N, Nuraini LH. A Bibliometric approach for Analyzing the Potential Essential Oil Microemulsions. Res J Pharm Technol. 2024; 17(1): 259-64.
12. Machaalani M, El Masri J, El Ayoubi LM, Matar B. Cancer research activity in the Arab world: a 15-year bibliometric analysis. J Egypt Public Health Assoc. 2022; 97(1): 26.
13. Hamad I, Harb AA, Bustanji Y. Liposome-Based Drug Delivery Systems in Cancer Research: An Analysis of Global Landscape Efforts and Achievements. Pharmaceutics 2024; 16(3).
14. Aleidi SM, Harb AA, Dahabiyeh LA, et al. Research Trend in The Inhibition of Transient Receptor Potential Vanilloid 1 (TRPV1): Bibliometric Analysis and Visualization. J Appl Pharm Sci. 2024; 14(11): 153-66.
15. van Eck NJ, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics 2010; 84(2): 523-38.
16. Aria M, Cuccurullo C. bibliometrix: An R-tool for comprehensive science mapping analysis. J Inf. 2017; 11(4): 959-75.
17. Bustanji Y, Shihab KHA, El-Huneidi W, et al. Analysis and mapping of global scientific research on human monkeypox over the past 20 years. Vet World. 2023; 16(4): 693-703.
18. Aykin-Burns N, Ahmad IM, Zhu Y, Oberley LW, Spitz DR. Increased levels of superoxide and H2O2 mediate the differential susceptibility of cancer cells versus normal cells to glucose deprivation. Biochem J. 2009; 418(1): 29-37.
19. Nicolai P, Battaglia P, Bignami M, et al. Endoscopic surgery for malignant tumors of the sinonasal tract and adjacent skull base: A 10-year experience. Am J Rhinol. 2008; 22(3): 308-16.
20. Oyelade ON, Ezugwu AES, Mohamed TIA, Abualigah L. Ebola Optimization Search Algorithm: A New Nature-Inspired Metaheuristic Optimization Algorithm. IEEE Access. 2022; 10: 16150-77.
21. Ferrari A, Sultan I, Huang TT, et al. Soft tissue sarcoma across the age spectrum: A population-based study from the surveillance epidemiology and end results database. Pediatr Blood Cancer 2011; 57(6): 943-9.
22. Sultan I, Rodriguez-Galindo C, Saab R, Yasir S, Casanova M, Ferrari A. Comparing children and adults with synovial sarcoma in the surveillance, epidemiology, and end results program, 1983 to 2005: An analysis of 1268 patients. Cancer. 2009; 115(15): 3537-47.
23. Al-Soud YA, Al-Dweri MN, Al-Masoudi NA. Synthesis, antitumor and antiviral properties of some 1,2,4-triazole derivatives. Farmaco. 2004; 59(10): 775-83.
24. Khdair A, Patil Y, Ma L, Dou QP, Shekhar MPV, Panyam J. Nanoparticle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistance. J Control Release. 2010; 141(2): 137-44.
25. Shen J, Gilmore EC, Marshall CA, et al. Mutations in PNKP cause microcephaly, seizures and defects in DNA repair. Nat Genet. 2010; 42(3): 245-9.
26. Heidari AA, Faris H, Aljarah I, Mirjalili S. An efficient hybrid multilayer perceptron neural network with grasshopper optimization. Soft Comput. 2019; 23(17): 7941-58.
27. Faris MAIE, Kacimi S, Al-Kurd RA, et al. Intermittent fasting during Ramadan attenuates proinflammatory cytokines and immune cells in healthy subjects. Nutr Res. 2012; 32(12): 947-55.
28. Taha MO, Bustanji Y, Al-Ghussein MAS, et al. Pharmacophore modeling, quantitative structure-activity relationship analysis, and in silico screening reveal potent glycogen synthase kinase-3β inhibitory activities for cimetidine, hydroxychloroquine, and gemifloxacin. J Med Chem 2008; 51(7): 2062-77.
29. Motawi TMK., Bustanji Y., El-Maraghy S., Taha MO., Al-Ghussein MAS. Evaluation of naproxen and cromolyn activities against cancer cells viability, proliferation, apoptosis, p53 and gene expression of survivin and caspase-3. J. Enzyme Inhib. Med. Chem. 2014; 29 (2): 153 - 161.
30. Khaleel S, Al-Hiari Y, Kasabri V, et al. Antiproliferative Properties of 7,8-Ethylene Diamine Chelator-Lipophilic Fluoroqui-nolone Derivatives Against Colorectal Cancer Cell Lines. Anti-Cancer Agents Med Chem. 2022; 22(5): 1012-28.
31. Gharaibeh L, Alshaer W, Wehaibi S, et al. Fabrication of aptamer-guided siRNA loaded lipopolyplexes for gene silencing of notch 1 in MDA-mb-231 triple negative breast cancer cell line. J Drug Deliv Sci Technol 2021; 65.
32. Lafi Z, Alshaer W, Hatmal MM, et al. Aptamer-functionalized pH-sensitive liposomes for a selective delivery of echinomycin into cancer cells. RSC Adv. 2021; 11(47): 29164-77.
33. Abdul Rasool Hassan B, Mohammed AH, Hallit S, Malaeb D, Hosseini H. Exploring the role of artificial intelligence in chemotherapy development, cancer diagnosis, and treatment: present achievements and future outlook. Front Oncol 2025; 15.
34. Tarawneh AS, Al Omari AK, Al-Khlifeh EM, et al. Non-Invasive Cancer Detection Using Blood Test and Predictive Modeling Approach. Adv Appl Bioinfo Chem 2025; 17: 159-78.
35. Qannita RA, Alalami AI, Harb AA, et al. Targeting Hypoxia-Inducible Factor-1 (HIF-1) in Cancer: Emerging Therapeutic Strategies and Pathway Regulation. Pharmaceuticals. 2024; 17(2).
36. Nandhini S, Radha R, Vadivu R. Docking of Hematoporphyrin on Various Anticancer Drugs Targeting Enzymes. Asian Journal of Pharmaceutical Research. 2016; 6(3): 123-30.
37. Merlin NJ, Selvin S, Sukesh TN. Nano Technology – Potential Applications in Medicine. Asian Journal of Research in Pharmaceutical Sciences. 2011; 1(2): 31-5.
38. Saadh MJ, Ahmed HH, Kareem RA, et al. Advanced machine learning framework for enhancing breast cancer diagnostics through transcriptomic profiling. Discov Oncol. 2025; 16(1).
39. Bajes HR, Oran SA, Bustanji YK. Chemical Composition and Antiproliferative and Antioxidant Activities of Methanolic Extract of Alcea setosa A. Malvaceae. Res J Pharm Technol. 2021; 14(12): 6447-54.
40. Bajes HR, Oran SA, Bustanji YK. Chemical Composition and Antiproliferative and Antioxidant Activities of Essential Oil from Juniperus phoenicea L. Cupressaceae. Res J Pharm Technol. 2022; 15(1): 153-9.
41. Bajes H, Oran S, Bustanji Y. Phytochemical Analysis, In vitro Assessment of Antioxidant Properties and Cytotoxic Potential of Thymus capitatus Essential Oil. Res J Pharm Technol. 2023; 16(3): 1100-8.
42. Fraihat A, Hamdan FR, Abu-Irmaileh B, Abbasi R, Abu-Irmaileh B, Bustanji Y. Evaluation of the antiproliferative activities of Anthemis bornmuelleri l. And Amygdalis communis l. extracts against six human cancer cell lines. Res J Pharm Technol. 2018; 11(6): 2512-6.
43. Sultan I, Alfaar AS, Sultan Y, Salman Z, Qaddoumi I. Trends in childhood cancer: Incidence and survival analysis over 45 years of SEER data. PLoS ONE 2025; 20(1 January).
44. Khamees N, Al-Ani A, Tamimi TA, et al. Epidemiology and clinical characteristics of colorectal cancer and advanced adenoma: a single center experience in Jordan. BMC Gastroenterol. 2025; 25(1).
45. Khader J, Al Mousa A, Al-Kayed S, et al. History and current state of radiation oncology services and practice in Jordan. JCO Glob Oncol. 2020; (6): 852-8.
46. Alsyouri NA, Al Shdifat W, Toubasi A, et al. Awareness of Smoking As a Risk Factor For Bladder Cancer: A Cross-Sectional Study in Jordan. Jordan Med J. 2025; 59(2): 302-11.
47. Abu-Helalah MA, Alshraideh HA, Al-Hanaqta MM, Arqoub KH. Quality of life and psychological well-being of colorectal cancer survivors in Jordan. Asian Pac J Cancer Preven. 2014; 15(18): 7653-64.
48. Hamdan KM, Al-Bashaireh AM, Al-Dalahmeh M, Saifan AR, Albqoor MA, Shaheen AM. Palliative care knowledge and attitudes toward end-of-life care among intensive care unit nurses in Jordan. Acute and Crit Care. 2023; 38(4): 469-78.
49. Alnajar M, Darawad M, Khater W, et al. Exploring Palliative Care Needs Among Patients With Cancer and Non-Cancer Serious Chronic Diseases: A Comparison Study. Am J Hospice Palliative Med. 2025; 42(1): 20-31.
50. Pramesh CS, Badwe RA, Bhoo-Pathy N, et al. Priorities for cancer research in low- and middle-income countries: a global perspective. Nat Med. 2022; 28(4): 649-57.